Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	inositol 1,4,5-trisphosphate-gated calcium channel activity	ITPR2 ITPR3	4.98e-05	3	82	2	GO:0005220
GeneOntologyCellularComponent	collagen type IV trimer	COL4A2 COL4A4	2.20e-04	6	81	2	GO:0005587
GeneOntologyCellularComponent	basement membrane collagen trimer	COL4A2 COL4A4	4.09e-04	8	81	2	GO:0098651
GeneOntologyCellularComponent	network-forming collagen trimer	COL4A2 COL4A4	4.09e-04	8	81	2	GO:0098642
GeneOntologyCellularComponent	collagen network	COL4A2 COL4A4	4.09e-04	8	81	2	GO:0098645
GeneOntologyCellularComponent	platelet dense tubular network membrane	ITPR2 ITPR3	5.25e-04	9	81	2	GO:0031095
GeneOntologyCellularComponent	axonal growth cone	TRPV2 LRP2 PARD3	7.07e-04	45	81	3	GO:0044295
GeneOntologyCellularComponent	chaperonin-containing T-complex	CCT8L2 CCT8L1P	7.97e-04	11	81	2	GO:0005832
GeneOntologyCellularComponent	platelet dense tubular network	ITPR2 ITPR3	7.97e-04	11	81	2	GO:0031094
Domain	InsP3_rcpt-bd	ITPR2 ITPR3	5.56e-05	3	81	2	IPR000493
Domain	C4	COL4A2 COL4A4	2.76e-04	6	81	2	SM00111
Domain	RIH_assoc	ITPR2 ITPR3	2.76e-04	6	81	2	PF08454
Domain	-	COL4A2 COL4A4	2.76e-04	6	81	2	2.170.240.10
Domain	Collagen_VI_NC	COL4A2 COL4A4	2.76e-04	6	81	2	IPR001442
Domain	RIH_assoc-dom	ITPR2 ITPR3	2.76e-04	6	81	2	IPR013662
Domain	RIH_dom	ITPR2 ITPR3	2.76e-04	6	81	2	IPR000699
Domain	Ins145_P3_rcpt	ITPR2 ITPR3	2.76e-04	6	81	2	IPR014821
Domain	Ryanodine_recept-rel	ITPR2 ITPR3	2.76e-04	6	81	2	IPR015925
Domain	C4	COL4A2 COL4A4	2.76e-04	6	81	2	PF01413
Domain	-	ITPR2 ITPR3	2.76e-04	6	81	2	1.25.10.30
Domain	RYDR_ITPR	ITPR2 ITPR3	2.76e-04	6	81	2	PF01365
Domain	NC1_IV	COL4A2 COL4A4	2.76e-04	6	81	2	PS51403
Domain	Ins145_P3_rec	ITPR2 ITPR3	2.76e-04	6	81	2	PF08709
Domain	EGF_3	FBLN7 FAT2 CNTNAP5 LRP2 SSPOP LDLR	5.50e-04	235	81	6	PS50026
Domain	LDLR_class-A_CS	LRP2 SSPOP LDLR	6.92e-04	40	81	3	IPR023415
Domain	MIR	ITPR2 ITPR3	8.17e-04	10	81	2	PS50919
Domain	MIR	ITPR2 ITPR3	8.17e-04	10	81	2	PF02815
Domain	MIR	ITPR2 ITPR3	8.17e-04	10	81	2	SM00472
Domain	MIR_motif	ITPR2 ITPR3	8.17e-04	10	81	2	IPR016093
Domain	EGF_1	FBLN7 FAT2 CNTNAP5 LRP2 SSPOP LDLR	8.43e-04	255	81	6	PS00022
Domain	Ldl_recept_a	LRP2 SSPOP LDLR	9.78e-04	45	81	3	PF00057
Domain	EGF_2	FBLN7 FAT2 CNTNAP5 LRP2 SSPOP LDLR	1.03e-03	265	81	6	PS01186
Domain	-	LRP2 SSPOP LDLR	1.04e-03	46	81	3	4.10.400.10
Domain	LDLRA_1	LRP2 SSPOP LDLR	1.18e-03	48	81	3	PS01209
Domain	LDLRA_2	LRP2 SSPOP LDLR	1.25e-03	49	81	3	PS50068
Domain	LDrepeatLR_classA_rpt	LRP2 SSPOP LDLR	1.25e-03	49	81	3	IPR002172
Domain	LDLa	LRP2 SSPOP LDLR	1.25e-03	49	81	3	SM00192
Domain	Ion_trans_dom	KCNV2 TRPV2 ITPR2 ITPR3	1.53e-03	114	81	4	IPR005821
Domain	Ion_trans	KCNV2 TRPV2 ITPR2 ITPR3	1.53e-03	114	81	4	PF00520
Domain	MORN	MORN1 JPH2	1.63e-03	14	81	2	SM00698
Domain	TIL_dom	LRP2 SSPOP	1.63e-03	14	81	2	IPR002919
Domain	Ldl_recept_b	LRP2 LDLR	1.63e-03	14	81	2	PF00058
Domain	LDLRB	LRP2 LDLR	1.63e-03	14	81	2	PS51120
Domain	MORN	MORN1 JPH2	1.88e-03	15	81	2	IPR003409
Domain	MORN	MORN1 JPH2	1.88e-03	15	81	2	PF02493
Domain	LY	LRP2 LDLR	1.88e-03	15	81	2	SM00135
Domain	LDLR_classB_rpt	LRP2 LDLR	1.88e-03	15	81	2	IPR000033
Domain	EGF_CA	FBLN7 FAT2 LRP2 LDLR	1.96e-03	122	81	4	SM00179
Domain	EGF-like_Ca-bd_dom	FBLN7 FAT2 LRP2 LDLR	2.08e-03	124	81	4	IPR001881
Domain	Cyclophilin-type_PPIase_CS	PPIG CWC27	3.03e-03	19	81	2	IPR020892
Domain	EGF	FBLN7 FAT2 CNTNAP5 LRP2 LDLR	3.56e-03	235	81	5	SM00181
Domain	FA58C	CNTNAP5 SSPOP	3.70e-03	21	81	2	SM00231
Domain	Cyclophilin-type_PPIase	PPIG CWC27	3.70e-03	21	81	2	IPR024936
Domain	FA58C_3	CNTNAP5 SSPOP	3.70e-03	21	81	2	PS50022
Domain	FA58C_1	CNTNAP5 SSPOP	3.70e-03	21	81	2	PS01285
Domain	FA58C_2	CNTNAP5 SSPOP	3.70e-03	21	81	2	PS01286
Domain	Cyclophilin-like_dom	PPIG CWC27	4.06e-03	22	81	2	IPR029000
Domain	CSA_PPIASE_2	PPIG CWC27	4.06e-03	22	81	2	PS50072
Domain	Pro_isomerase	PPIG CWC27	4.06e-03	22	81	2	PF00160
Domain	-	PPIG CWC27	4.06e-03	22	81	2	2.40.100.10
Domain	Cyclophilin-type_PPIase_dom	PPIG CWC27	4.06e-03	22	81	2	IPR002130
Domain	CSA_PPIASE_1	PPIG CWC27	4.06e-03	22	81	2	PS00170
Domain	EGF-like_dom	FBLN7 FAT2 CNTNAP5 LRP2 LDLR	4.55e-03	249	81	5	IPR000742
Domain	F5_F8_type_C	CNTNAP5 SSPOP	4.82e-03	24	81	2	PF00754
Domain	FA58C	CNTNAP5 SSPOP	4.82e-03	24	81	2	IPR000421
Domain	ABC_membrane	ABCB11 TAP1	4.82e-03	24	81	2	PF00664
Domain	Ricin_B_lectin	GALNT1 GALNT13	5.22e-03	25	81	2	PF00652
Domain	EGF_CA	FBLN7 LRP2 LDLR	6.21e-03	86	81	3	PF07645
Domain	ABC_TM1F	ABCB11 TAP1	6.53e-03	28	81	2	PS50929
Domain	RICIN	GALNT1 GALNT13	6.53e-03	28	81	2	SM00458
Domain	ABC1_TM_dom	ABCB11 TAP1	6.53e-03	28	81	2	IPR011527
Domain	RICIN_B_LECTIN	GALNT1 GALNT13	6.53e-03	28	81	2	PS50231
Domain	Ricin_B_lectin	GALNT1 GALNT13	7.47e-03	30	81	2	IPR000772
Domain	Glycos_transf_2	GALNT1 GALNT13	7.47e-03	30	81	2	PF00535
Domain	Glyco_trans_2-like	GALNT1 GALNT13	7.47e-03	30	81	2	IPR001173
Domain	-	FAT2 CNTNAP5 CLSTN2	8.17e-03	95	81	3	2.60.120.200
Domain	EGF_Ca-bd_CS	FBLN7 LRP2 LDLR	8.65e-03	97	81	3	IPR018097
Pathway	BIOCARTA_VITCB_PATHWAY	COL4A2 COL4A4 SLC2A14	1.73e-05	12	62	3	MM1526
Pubmed	Genetic determinants of serum lipid levels in Chinese subjects: a population-based study in Shanghai, China.	ABCB11 LDLR ALOX5	7.28e-07	8	83	3	19888660
Pubmed	Gelatinase B (MMP-9) is not essential in the normal kidney and does not influence progression of renal disease in a mouse model of Alport syndrome.	COL4A2 COL4A4 MMP2	1.09e-06	9	83	3	10880400
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	TRMT9B HIVEP2 MCM8 MORN1 MYO6 POLG RPS6KB1 TRIOBP ZFHX2 SLITRK3 PACRG PARD3 PBX3 SSPOP CREBBP	2.18e-06	1489	83	15	28611215
Pubmed	Isoform diversity of the inositol trisphosphate receptor in cell types of mouse origin.	ITPR2 ITPR3	5.63e-06	2	83	2	9065779
Pubmed	PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease.	PBX3 MEIS1	5.63e-06	2	83	2	26747896
Pubmed	Revisiting the human polypeptide GalNAc-T1 and T13 paralogs.	GALNT1 GALNT13	5.63e-06	2	83	2	27913570
Pubmed	Chinese yellow wine and red wine inhibit matrix metalloproteinase-2 and improve atherosclerotic plaque in LDL receptor knockout mice.	MMP2 LDLR	5.63e-06	2	83	2	20370796
Pubmed	Cloning and characterization of human type 2 and type 3 inositol 1,4,5-trisphosphate receptors.	ITPR2 ITPR3	5.63e-06	2	83	2	8081734
Pubmed	Structures of collagen IV globular domains: insight into associated pathologies, folding and network assembly.	COL4A2 COL4A4	5.63e-06	2	83	2	30443360
Pubmed	Molecular cloning of mouse type 2 and type 3 inositol 1,4,5-trisphosphate receptors and identification of a novel type 2 receptor splice variant.	ITPR2 ITPR3	5.63e-06	2	83	2	15632133
Pubmed	High-resolution maps of the murine Chromosome 2 region containing the cholesterol gallstone locus, Lith1.	LRP2 ABCB11	5.63e-06	2	83	2	10556425
Pubmed	Expression of IP3 receptor isoforms at the nodes of Ranvier in rat sciatic nerve.	ITPR2 ITPR3	5.63e-06	2	83	2	17496801
Pubmed	Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice.	LDLR ALOX5	5.63e-06	2	83	2	12142344
Pubmed	Mice lacking inositol 1,4,5-trisphosphate receptors exhibit dry eye.	ITPR2 ITPR3	5.63e-06	2	83	2	24901844
Pubmed	Adrenergic inhibition facilitates normalization of extracellular potassium after cortical spreading depolarization.	ITPR2 ITPR3	5.63e-06	2	83	2	33854148
Pubmed	Heparin inhibits the production of matrix metalloproteinase-2 and improves atherosclerosis in LDL receptor-deficient mice.	MMP2 LDLR	5.63e-06	2	83	2	19940766
Pubmed	Pancreatic protease activation by alcohol metabolite depends on Ca2+ release via acid store IP3 receptors.	ITPR2 ITPR3	5.63e-06	2	83	2	19528657
Pubmed	Determination of relative amounts of inositol trisphosphate receptor mRNA isoforms by ratio polymerase chain reaction.	ITPR2 ITPR3	5.63e-06	2	83	2	8063813
Pubmed	IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism.	ITPR2 ITPR3	5.63e-06	2	83	2	16195467
Pubmed	Inositol (1,4,5)-trisphosphate receptor links to filamentous actin are important for generating local Ca2+ signals in pancreatic acinar cells.	ITPR2 ITPR3	5.63e-06	2	83	2	15713744
Pubmed	Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation.	COL4A2 COL4A4 LDLR	1.04e-05	18	83	3	9160753
Pubmed	Evidence that type I, II, and III inositol 1,4,5-trisphosphate receptors can occur as integral plasma membrane proteins.	ITPR2 ITPR3	1.69e-05	3	83	2	10874040
Pubmed	Abnormal distribution of inositol 1,4,5-trisphosphate receptors in human muscle can be related to altered calcium signals and gene expression in Duchenne dystrophy-derived cells.	ITPR2 ITPR3	1.69e-05	3	83	2	20395455
Pubmed	Inositol 1,4,5-trisphosphate receptors are autoantibody target antigens in patients with Sjögren's syndrome and other systemic rheumatic diseases.	ITPR2 ITPR3	1.69e-05	3	83	2	17437169
Pubmed	Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability.	LDLR ALOX5	1.69e-05	3	83	2	16698924
Pubmed	Decreased olfactory mucus secretion and nasal abnormality in mice lacking type 2 and type 3 IP3 receptors.	ITPR2 ITPR3	1.69e-05	3	83	2	18547250
Pubmed	Inositol 1,4,5-trisphosphate receptor gene variants are related to the risk of breast cancer in a Chinese population.	ITPR2 ITPR3	1.69e-05	3	83	2	36350267
Pubmed	The versatility and universality of calcium signalling.	ITPR2 ITPR3	1.69e-05	3	83	2	11413485
Pubmed	MMP-2 inhibits PCSK9-induced degradation of the LDL receptor in Hepa1-c1c7 cells.	MMP2 LDLR	1.69e-05	3	83	2	25613181
Pubmed	Using concatenated subunits to investigate the functional consequences of heterotetrameric inositol 1,4,5-trisphosphate receptors.	ITPR2 ITPR3	1.69e-05	3	83	2	26009177
Pubmed	CalDAG-GEFI Deficiency Reduces Atherosclerotic Lesion Development in Mice.	LDLR RASGRP2	1.69e-05	3	83	2	26988592
Pubmed	Receptor-activated single channels in intact human platelets.	ITPR2 ITPR3	1.69e-05	3	83	2	1693919
Pubmed	Functional inositol 1,4,5-trisphosphate receptors assembled from concatenated homo- and heteromeric subunits.	ITPR2 ITPR3	1.69e-05	3	83	2	23955339
Pubmed	Usher syndrome IIIA gene clarin-1 is essential for hair cell function and associated neural activation.	MYO6 CLRN1	1.69e-05	3	83	2	19414487
Pubmed	Type 3 Inositol 1,4,5-Trisphosphate Receptor is a Crucial Regulator of Calcium Dynamics Mediated by Endoplasmic Reticulum in HEK Cells.	ITPR2 ITPR3	1.69e-05	3	83	2	31979185
Pubmed	Tsg101 regulates PI(4,5)P2/Ca(2+) signaling for HIV-1 Gag assembly.	ITPR2 ITPR3	1.69e-05	3	83	2	24904548
Pubmed	Cyclic AMP responsive element-binding protein induces metastatic renal cell carcinoma by mediating the expression of matrix metallopeptidase-2/9 and proteins associated with epithelial-mesenchymal transition.	MMP2 CREBBP	1.69e-05	3	83	2	28487942
Pubmed	Differential distribution of inositol trisphosphate receptor isoforms in mouse oocytes.	ITPR2 ITPR3	1.69e-05	3	83	2	9858485
Pubmed	Pbx3 deficiency results in central hypoventilation.	PBX3 MEIS1	1.69e-05	3	83	2	15466398
Pubmed	The collagen binding domain of gelatinase A modulates degradation of collagen IV by gelatinase B.	COL4A4 MMP2	1.69e-05	3	83	2	19109975
Pubmed	Rescue of calcineurin Aα(-/-) mice reveals a novel role for the α isoform in the salivary gland.	ITPR2 ITPR3	1.69e-05	3	83	2	21435446
Pubmed	Expression of inositol 1,4,5-trisphosphate receptors in mouse oocytes and early embryos: the type I isoform is upregulated in oocytes and downregulated after fertilization.	ITPR2 ITPR3	1.69e-05	3	83	2	9808793
Pubmed	RNA interference-mediated silencing of laminin receptor 1 (LR1) suppresses migration and invasion and down-regulates matrix metalloproteinase (MMP)-2 and MMP-9 in trophoblast cells: implication in the pathogenesis of preeclampsia.	RPSA MMP2	1.69e-05	3	83	2	23729238
Pubmed	AG-9, an Elastin-Derived Peptide, Increases In Vitro Oral Tongue Carcinoma Cell Invasion, through an Increase in MMP-2 Secretion and MT1-MMP Expression, in a RPSA-Dependent Manner.	RPSA MMP2	1.69e-05	3	83	2	33396696
Pubmed	Collagen types in various layers of the human aorta and their changes with the atherosclerotic process.	COL4A2 COL4A4	1.69e-05	3	83	2	3089234
Pubmed	Type 2 and type 3 inositol 1,4,5-trisphosphate (IP3) receptors promote the differentiation of granule cell precursors in the postnatal cerebellum.	ITPR2 ITPR3	1.69e-05	3	83	2	18194433
Pubmed	Polypeptide N-Acetylgalactosaminyltransferase 13 Contributes to Neurogenesis via Stabilizing the Mucin-type O-Glycoprotein Podoplanin.	GALNT1 GALNT13	1.69e-05	3	83	2	27629416
Pubmed	IP3 receptors regulate vascular smooth muscle contractility and hypertension.	ITPR2 ITPR3	1.69e-05	3	83	2	27777977
Pubmed	Pbx3 and Meis1 cooperate through multiple mechanisms to support Hox-induced murine leukemia.	PBX3 MEIS1	1.69e-05	3	83	2	25911551
Pubmed	Differential inositol 1,4,5-trisphosphate receptor signaling in a neuronal cell line.	ITPR2 ITPR3	1.69e-05	3	83	2	17581770
Pubmed	Predominant role of type 1 IP3 receptor in aortic vascular muscle contraction.	ITPR2 ITPR3	1.69e-05	3	83	2	18241669
Pubmed	Granulosa cells express three inositol 1,4,5-trisphosphate receptor isoforms: cytoplasmic and nuclear Ca2+ mobilization.	ITPR2 ITPR3	1.69e-05	3	83	2	19068129
Pubmed	Dangerous liaisons: cooperation between Pbx3, Meis1 and Hoxa9 in leukemia.	PBX3 MEIS1	1.69e-05	3	83	2	26130510
Pubmed	Liver receptor homolog 1 transcriptionally regulates human bile salt export pump expression.	NR5A2 ABCB11	1.69e-05	3	83	2	18270374
Pubmed	Molecular basis of the isoform-specific ligand-binding affinity of inositol 1,4,5-trisphosphate receptors.	ITPR2 ITPR3	1.69e-05	3	83	2	17327232
Pubmed	Nuclear inositol 1,4,5-trisphosphate receptors regulate local Ca2+ transients and modulate cAMP response element binding protein phosphorylation.	ITPR2 ITPR3	1.69e-05	3	83	2	16014380
Pubmed	Cloning and characterization of a new human UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase, designated pp-GalNAc-T13, that is specifically expressed in neurons and synthesizes GalNAc alpha-serine/threonine antigen.	GALNT1 GALNT13	1.69e-05	3	83	2	12407114
Pubmed	SUMOylation-dependent LRH-1/PROX1 interaction promotes atherosclerosis by decreasing hepatic reverse cholesterol transport.	NR5A2 LDLR	1.69e-05	3	83	2	25176150
Pubmed	Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential.	PBX3 MEIS1	1.69e-05	3	83	2	17942707
Pubmed	Knockdown of the type 2 and 3 inositol 1,4,5-trisphosphate receptors suppresses muscarinic antinociception in mice.	ITPR2 ITPR3	1.69e-05	3	83	2	17890015
Pubmed	Angiotensinogen and Megalin Interactions Contribute to Atherosclerosis-Brief Report.	LRP2 LDLR	1.69e-05	3	83	2	30567480
Pubmed	Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes.	ITPR2 ITPR3	1.69e-05	3	83	2	23983250
Pubmed	Activation of the inositol (1,4,5)-triphosphate calcium gate receptor is required for HIV-1 Gag release.	ITPR2 ITPR3	1.69e-05	3	83	2	20427533
Pubmed	The atypical homeoprotein Pbx1a participates in the axonal pathfinding of mesencephalic dopaminergic neurons.	ALDH1A1 PBX3 MEIS1	1.95e-05	22	83	3	22748019
Pubmed	Galnt11 regulates kidney function by glycosylating the endocytosis receptor megalin to modulate ligand binding.	GALNT1 LRP2 GALNT13	2.56e-05	24	83	3	31740596
Pubmed	Loss of IP3R-dependent Ca2+ signalling in thymocytes leads to aberrant development and acute lymphoblastic leukemia.	ITPR2 ITPR3	3.37e-05	4	83	2	25215520
Pubmed	Nature and the multiple functions of the 67-kD elastin-/laminin binding protein.	COL4A2 COL4A4	3.37e-05	4	83	2	7827955
Pubmed	Abnormal taste perception in mice lacking the type 3 inositol 1,4,5-trisphosphate receptor.	ITPR2 ITPR3	3.37e-05	4	83	2	17925404
Pubmed	IRE1α/XBP1-mediated branch of the unfolded protein response regulates osteoclastogenesis.	ITPR2 ITPR3	3.37e-05	4	83	2	26193638
Pubmed	USH3A transcripts encode clarin-1, a four-transmembrane-domain protein with a possible role in sensory synapses.	MYO6 CLRN1	3.37e-05	4	83	2	12080385
Pubmed	PCSK9 is required for the disposal of non-acetylated intermediates of the nascent membrane protein BACE1.	CREBBP LDLR	3.37e-05	4	83	2	18660751
Pubmed	Inhibition of hypoxia inducible factor-1α attenuates abdominal aortic aneurysm progression through the down-regulation of matrix metalloproteinases.	MMP2 LDLR	3.37e-05	4	83	2	27363580
Pubmed	Alternative splice variants of hTrp4 differentially interact with the C-terminal portion of the inositol 1,4,5-trisphosphate receptors.	ITPR2 ITPR3	3.37e-05	4	83	2	11163362
Pubmed	Binding of internalized receptors to the PDZ domain of GIPC/synectin recruits myosin VI to endocytic vesicles.	MYO6 LRP2	3.37e-05	4	83	2	16908842
Pubmed	Inositol 1, 4, 5-trisphosphate receptor interacts with the SNARE domain of syntaxin 1B.	ITPR2 ITPR3	3.37e-05	4	83	2	21424589
Pubmed	Loss of IP3 Receptor-Mediated Ca2+ Release in Mouse B Cells Results in Abnormal B Cell Development and Function.	ITPR2 ITPR3	3.37e-05	4	83	2	28615414
Pubmed	Pbx/Meis deficiencies demonstrate multigenetic origins of congenital heart disease.	PBX3 MEIS1	3.37e-05	4	83	2	18723445
Pubmed	Distinct localization and function of (1,4,5)IP(3) receptor subtypes and the (1,3,4,5)IP(4) receptor GAP1(IP4BP) in highly purified human platelet membranes.	ITPR2 ITPR3	3.37e-05	4	83	2	10828023
Pubmed	IP3R-mediated Ca2+ signals govern hematopoietic and cardiac divergence of Flk1+ cells via the calcineurin-NFATc3-Etv2 pathway.	ITPR2 ITPR3	3.37e-05	4	83	2	28419336
Pubmed	IP3R-mediated Ca2+ signaling controls B cell proliferation through metabolic reprogramming.	ITPR2 ITPR3	3.37e-05	4	83	2	35494252
Pubmed	UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferases: completion of the family tree.	GALNT1 GALNT13	5.60e-05	5	83	2	22186971
Pubmed	Interaction of coagulation factor VIII with members of the low-density lipoprotein receptor family follows common mechanism and involves consensus residues within the A2 binding site 484-509.	LRP2 LDLR	5.60e-05	5	83	2	18685438
Pubmed	In vitro interactions of oxidatively modified LDL with type I, II, III, IV, and V collagen, laminin, fibronectin, and poly-D-lysine.	COL4A2 COL4A4	5.60e-05	5	83	2	9409248
Pubmed	Role of nuclear receptor coactivator 3 (Ncoa3) in pluripotency maintenance.	NR5A2 CREBBP	5.60e-05	5	83	2	22977234
Pubmed	Expression of Meis and Pbx genes and their protein products in the developing telencephalon: implications for regional differentiation.	PBX3 MEIS1	5.60e-05	5	83	2	10842069
Pubmed	InsP₃receptors and Orai channels in pancreatic acinar cells: co-localization and its consequences.	ITPR2 ITPR3	5.60e-05	5	83	2	21568942
Pubmed	Expression of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase isoforms in murine tissues determined by real-time PCR: a new view of a large family.	GALNT1 GALNT13	5.60e-05	5	83	2	12651884
Pubmed	Hypoxic adaptation engages the CBP/CREST-induced coactivator complex of Creb-HIF-1α in transactivating murine neuroblastic glucose transporter.	SLC2A14 CREBBP	5.60e-05	5	83	2	23321477
Pubmed	HOXA9 forms triple complexes with PBX2 and MEIS1 in myeloid cells.	PBX3 MEIS1	5.60e-05	5	83	2	10082572
Pubmed	Calmodulin protects against alcohol-induced pancreatic trypsinogen activation elicited via Ca2+ release through IP3 receptors.	ITPR2 ITPR3	5.60e-05	5	83	2	21436055
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	TPR UBAP2 FAM193A MYO6 PARG COPS4 RPSA EIF3I PPP6R2 AHSA1	7.69e-05	934	83	10	33916271
Pubmed	Roles of I(f) and intracellular Ca2+ release in spontaneous activity of ventricular cardiomyocytes during murine embryonic development.	ITPR2 ITPR3	8.39e-05	6	83	2	23463619
Pubmed	Extracellular matrix of the human optic nerve head.	COL4A2 COL4A4	8.39e-05	6	83	2	2426947
Pubmed	Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein.	LRP2 LDLR	8.39e-05	6	83	2	9837937
Pubmed	Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging.	ITPR2 ITPR3	8.39e-05	6	83	2	25966694
Pubmed	Complex inheritance of the 5-lipoxygenase locus influencing atherosclerosis in mice.	LDLR ALOX5	8.39e-05	6	83	2	16624897
Pubmed	Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome.	COL4A2 COL4A4	8.39e-05	6	83	2	10534397
Pubmed	Inhibition of myeloid differentiation by Hoxa9, Hoxb8, and Meis homeobox genes.	PBX3 MEIS1	8.39e-05	6	83	2	11438208
Pubmed	Characterization of TALE genes expression during the first lineage segregation in mammalian embryos.	PBX3 MEIS1	8.39e-05	6	83	2	22987645
Pubmed	Developmental distribution of collagen IV isoforms and relevance to ocular diseases.	COL4A2 COL4A4	8.39e-05	6	83	2	19275937
GeneFamily	Inositol 1,4,5-triphosphate receptors\|Protein phosphatase 1 regulatory subunits	ITPR2 ITPR3	2.43e-05	3	52	2	297
GeneFamily	ATP binding cassette subfamily B	ABCB11 TAP1	4.39e-04	11	52	2	806
GeneFamily	Low density lipoprotein receptors	LRP2 LDLR	6.20e-04	13	52	2	634
GeneFamily	Cadherin related	FAT2 CLSTN2	1.07e-03	17	52	2	24
GeneFamily	Cyclophilin peptidylprolyl isomerases	PPIG CWC27	1.34e-03	19	52	2	909
GeneFamily	Polypeptide N-acetylgalactosaminyltransferases	GALNT1 GALNT13	1.49e-03	20	52	2	433
GeneFamily	TALE class homeoboxes and pseudogenes	PBX3 MEIS1	2.52e-03	26	52	2	526
GeneFamily	Collagens	COL4A2 COL4A4	7.74e-03	46	52	2	490
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CAPN12 DLGAP1 LRP2 CLSTN2 PARD3 ALPK2	1.38e-06	187	83	6	9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CAPN12 DLGAP1 LRP2 CLSTN2 PARD3 ALPK2	1.46e-06	189	83	6	3b48b0d220cc24d5170713d61fa91f5bb6c21841
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CAPN12 DLGAP1 LRP2 CLSTN2 PARD3 ALPK2	1.46e-06	189	83	6	28b502611829e4a24caff2562545c7db97686099
ToppCell	COVID-19-kidney-PCT-S2\|kidney / Disease (COVID-19 only), tissue and cell type	CAPN12 DLGAP1 LRP2 CLSTN2 PARD3 ALPK2	1.46e-06	189	83	6	0be5c669b6b308bd98ddb70c84877c62a6244bbd
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CAPN12 DLGAP1 LRP2 CLSTN2 PARD3 ALPK2	1.51e-06	190	83	6	989d4eefd22d66ecb857836f8fdbcf41e3047f84
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A2 DLGAP1 LRP2 CLSTN2 PARD3 ALPK2	1.56e-06	191	83	6	1cb02007adb344f17ef73d58890f91298c7cf5a1
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CAPN12 COL4A2 DLGAP1 LRP2 CLSTN2 ALPK2	1.92e-06	198	83	6	be305d89d48c67ce922fa71aaf15e24d00c89ff6
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WDR64 KCNV2 LRP2 PTCHD4 GALNT13	1.24e-05	160	83	5	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WDR64 KCNV2 LRP2 PTCHD4 GALNT13	1.24e-05	160	83	5	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A2 COL4A4 IGFN1 GAL3ST4 MEIS1	1.32e-05	162	83	5	5f009b231f21861afee9cc0c569082e1135f929c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A2 COL4A4 IGFN1 GAL3ST4 MEIS1	1.32e-05	162	83	5	b936f8040dcd4db621ccded19237af8df7d0ed6e
ToppCell	Control\|World / group, cell type (main and fine annotations)	DLGAP1 MYO6 LRP2 PARD3 LDLR	1.57e-05	168	83	5	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	COL4A2 COL4A4 MYO6 PARD3 LDLR	1.66e-05	170	83	5	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	AT1-AT2_cells-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	COL4A2 COL4A4 DLGAP1 ERVW-1 EHD2	1.91e-05	175	83	5	9a95ab5c361ebaa8747983c5a0d69025682a19ad
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	COL4A2 COL4A4 PTCHD4 SSPOP RASGRP2	2.43e-05	184	83	5	ae0a77e3e520a246b17776bb19503519636b02ee
ToppCell	3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor_MEMP\|bone_marrow / Manually curated celltypes from each tissue	CNTNAP5 ZNRF1 ALDH1A1 MEIS1 EHD2	2.43e-05	184	83	5	b81a2a95944cee8fec13d63dc0d95496e67aa937
ToppCell	COVID-19_Moderate-HSPC\|COVID-19_Moderate / disease group, cell group and cell class	ZNRF1 ALDH1A1 MMP2 MEIS1 EHD2	2.49e-05	185	83	5	cacc6ab5f26f6c803894567fb838ea06eaa7efe5
ToppCell	(8)_CD34_progenitor\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	ZNRF1 ALDH1A1 MMP2 MEIS1 EHD2	2.56e-05	186	83	5	943c604a7cd873faf510096d094100512ba2d6bc
ToppCell	(8)_CD34_progenitor\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	ZNRF1 ALDH1A1 MMP2 MEIS1 EHD2	2.56e-05	186	83	5	e69a986b8618effd61875fda528a2e44aab11868
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CAPN12 DLGAP1 LRP2 PARD3 ALPK2	2.56e-05	186	83	5	b87acc80b7baa41681e4ed11d5537b9fbf5832f5
ToppCell	COVID-19-kidney-tDL\|kidney / Disease (COVID-19 only), tissue and cell type	CAPN12 DLGAP1 LRP2 PARD3 ALPK2	2.62e-05	187	83	5	d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CAPN12 DLGAP1 LRP2 CLSTN2 ALPK2	2.76e-05	189	83	5	204ab61ae606b2d9be0cb6bf6a83a011740693a8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CAPN12 DLGAP1 LRP2 CLSTN2 ALPK2	2.76e-05	189	83	5	13fd07cc408a9486f61a7b2c3a132c52d14b438d
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-bronchial_smooth_muscle_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A4 JPH2 GAL3ST4 CLSTN2 PTCHD4	2.76e-05	189	83	5	4dc32b463546bbe7250dddd281b92ad17ec22da1
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-Airway_Smooth_Muscle\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A4 JPH2 GAL3ST4 CLSTN2 PTCHD4	2.76e-05	189	83	5	0d06bf0d7191d13a1c4f30a7881e7ea1093bfd6f
ToppCell	LPS_only-Stromal_mesenchymal\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL4A2 DLGAP1 ALDH1A1 MMP2 MEIS1	2.98e-05	192	83	5	162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCell	LA-14._Fibroblast_III\|LA / Chamber and Cluster_Paper	COL4A2 COL4A4 HIVEP2 LDLR MEIS1	3.05e-05	193	83	5	7426c291bac59e539c427bcaae18abc7d397d44e
ToppCell	18-Airway-Mesenchymal-Pericyte\|Airway / Age, Tissue, Lineage and Cell class	COL4A2 IGFN1 SLC2A14 JPH2 EHD2	3.05e-05	193	83	5	9f4ba9c29ab8071d57e4187085ec3a47ab61e968
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DLGAP1 MYO6 LRP2 PACRG PARD3	3.13e-05	194	83	5	7002937e8903e037332a215d00fbc7c7843b33f2
ToppCell	LA-14._Fibroblast_III\|World / Chamber and Cluster_Paper	COL4A2 COL4A4 HIVEP2 CLSTN2 MEIS1	3.13e-05	194	83	5	803fa83ceada17c38ca9f933b888f7e7b0b90761
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_2\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	MYO6 CNIH4 TRPV2 ALDH1A1 ALOX5	3.29e-05	196	83	5	fe90501010128b72e6711c567cb04b012f1520a4
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL4A2 MMP2 PBX3 MEIS1 EHD2	3.45e-05	198	83	5	ebceb11f50b8a6ebb7629fdbd3d31fb131ace6fd
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	COL4A2 HIVEP2 MYO6 TAP1 EHD2	3.62e-05	200	83	5	edb64556b3fefe3144f73b6efe23b9ffd34091d2
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CAPN12 LRP2 CLSTN2 ALDH1A1 ALPK2	3.62e-05	200	83	5	105564ee05bd11685b5747ee32d5350cf3c2e2e1
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Serpinf1-Serpinf1_Clrn1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ST6GALNAC1 FBLN7 PBX3 CLRN1	3.69e-05	100	83	4	2e1c6fa2b48a6e3367b76b79dec58aea9c4662e0
ToppCell	(09)_Ionocytes-(3)_72hpi\|(09)_Ionocytes / shred by cell type and Timepoint	UBAP2 POLG ZFHX2 ALOX5	5.36e-05	110	83	4	fce7d5a0617fc664b657f5bb9abb290e7cc234cb
ToppCell	Control-Epithelial_alveolar-AT_2-AT1-AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ST6GALNAC1 ZFHX2 GRHL3 ALPK2	6.81e-05	117	83	4	c6fc72608d56a389bcd87b5dc98a11e39b79bcb2
ToppCell	Smart-seq2-blood_(Smart-seq2)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ZFHX2 ALDH1A1 MEIS1 EHD2	1.73e-04	149	83	4	e99b7cd3728ce76b365526734c2e7f845b2e62c8
ToppCell	Smart-seq2-blood_(Smart-seq2)-hematologic-hematopoietic_progenitor\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ZFHX2 ALDH1A1 MEIS1 EHD2	1.73e-04	149	83	4	6a28dd4530ed411747fdfe743db138a1b5547ed7
ToppCell	ileum-BEST4+_Enterocytes\|ileum / shred on tissue and cell subclass	GRHL3 PBX3 MEIS1 ITPR2	1.97e-04	154	83	4	608e9c982125e0c2c15b86b1920813845a0db81f
ToppCell	343B-Lymphocytic-CD4_T-cell-Treg_cell_1\|343B / Donor, Lineage, Cell class and subclass (all cells)	PCF11 FBLN7 FAM193A SLC2A14	2.02e-04	155	83	4	a4ff78e2efc6fe9a513bb2b64e5848f2ce65a09f
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Vcan_(SNc)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	NUTM1 NR5A2 CCT8L1P	2.02e-04	61	83	3	12de8c495c7f47ecd720f29a573471705603732a
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Vcan_(SNc)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	NUTM1 NR5A2 CCT8L1P	2.02e-04	61	83	3	a655232c6d92335eb086723ab9b05eb3a5479b68
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Nefm\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	FAT2 WDR64 ALPK2	2.12e-04	62	83	3	3eec7f31de7cc24762c5b180475650676437dc76
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Nefm-Inhibitory_Neuron.Chat-Gad1Gad2-Slc17a8.Nefm_(Globus_Pallidus/Nucleus_Basalis_(GP/NB),_cholinergic)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	FAT2 WDR64 ALPK2	2.12e-04	62	83	3	f5f5441f5be00ab80a7827c4af1afbe45c552c2e
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Nefm-Inhibitory_Neuron.Chat-Gad1Gad2-Slc17a8.Nefm_(Globus_Pallidus/Nucleus_Basalis_(GP/NB),_cholinergic)-\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	FAT2 WDR64 ALPK2	2.12e-04	62	83	3	6e81a37b9defa96528654bee1b23152108d9c0b7
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A4 SLITRK3 MEIS1 RASGRP2	2.22e-04	159	83	4	e812cbde59188924c6277c3feadf1a9592fa62a4
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A4 SLITRK3 MEIS1 RASGRP2	2.22e-04	159	83	4	2607b562903228274fbd96168ba826782fab0b53
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ST6GALNAC1 RWDD2B ALDH1A1 PARD3	2.33e-04	161	83	4	9cfbbcd38ec2e75376bbc26001964b6991ad0e21
ToppCell	facs-Trachea-18m-Epithelial-glandular_epithelial-lung_secretory_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL4A4 LRP2 CLSTN2 ALPK2	2.50e-04	164	83	4	cdb8cd2d6b369189ea77e4946738e2816d502e03
ToppCell	facs-Trachea-18m-Epithelial-glandular_epithelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL4A4 LRP2 CLSTN2 ALPK2	2.50e-04	164	83	4	5dbfcdd450f652b16d97da53b528d4584b0eabcf
ToppCell	facs-Trachea-18m-Epithelial-glandular_epithelial-lung_secretory_cell-mucous\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL4A4 LRP2 CLSTN2 ALPK2	2.50e-04	164	83	4	f1423f4434af4af9c60c8a5b0b0abec4a7df9401
ToppCell	356C-Endothelial_cells-Endothelial-E\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PPIG ZFHX2 MMP2 LDLR	2.80e-04	169	83	4	0425d2580ed325178f522c0093ff4623de6ce7a8
ToppCell	356C-Endothelial_cells-Endothelial-E-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PPIG ZFHX2 MMP2 LDLR	2.80e-04	169	83	4	fec669968a77060bd77ee8695034e35a642c984f
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A2 CLSTN2 PTCHD4 RASGRP2	2.87e-04	170	83	4	1f994b690e881106a5d54b3080ccce6260bc3ac5
ToppCell	TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9\|TCGA-Bladder / Sample_Type by Project: Shred V9	ST6GALNAC1 FAT2 GALNT1 ABCB11	2.93e-04	171	83	4	adbcfa4bf6bc1c604535a24435924cdb091e2dd7
ToppCell	primary_auditory_cortex_(A1C)\|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	COL4A2 SLC2A14 PARD3 MEIS1	3.00e-04	172	83	4	20ea9db009370aa6235365ce93e153eb5b28db94
ToppCell	AT1_cells-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	COL4A2 COL4A4 LDLR EHD2	3.06e-04	173	83	4	3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e
ToppCell	Ionocyte-iono-2\|World / Class top	PDPR ABCB11 GALNT13 ITPR2	3.06e-04	173	83	4	e5ec28ccc5e048fd98de4c876e5c53b866b66228
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	CNIH4 CWC27 CRAT RASGRP2	3.13e-04	174	83	4	eaaf17a06efc09ed4752b449827b1f0f424d3dad
ToppCell	AT1-AT2_cells-Donor_06\|World / lung cells shred on cell class, cell subclass, sample id	COL4A2 COL4A4 ERVW-1 EHD2	3.20e-04	175	83	4	bdd85ba280648a0283c1984662a34c7b840f64dd
ToppCell	facs-Aorta\|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A2 NR5A2 LRP2 SSPOP	3.27e-04	176	83	4	0b3491451be02c18a16cdb875645be47eb867a7f
ToppCell	AT1_cells-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	COL4A2 COL4A4 GALNT13 EHD2	3.27e-04	176	83	4	458720776b0151cd55acc352d509599cb62f0ca8
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CAPN12 SLC2A14 LRP2 ALPK2	3.27e-04	176	83	4	1595dbeee336a81e581325d63208ec6262664ee9
ToppCell	AT1_cells-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	COL4A2 COL4A4 LDLR EHD2	3.34e-04	177	83	4	3128b8d04687acee1ac4190b2569d6328b98eaf3
ToppCell	droplet-Lung-nan-3m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CAPN12 TRMT9B CLSTN2 SSPOP	3.34e-04	177	83	4	65709bd546cb1ec6aa2ddd8b2adb46e174eb9a9a
ToppCell	droplet-Lung-nan-3m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CAPN12 TRMT9B CLSTN2 SSPOP	3.34e-04	177	83	4	8684d47a547e2a06496f15e8da0200ecddc431e0
ToppCell	control-Others-CD34+_GATA2+_cells\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	ZNRF1 MMP2 MEIS1 EHD2	3.41e-04	178	83	4	2120bd3e099b0b271bf079db9827a2f3eee2f909
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Macroglial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DLGAP1 SLITRK3 RWDD2B GRHL3	3.41e-04	178	83	4	ef490b45901b2e6dedb519540fa3ae4e4db3a9ba
ToppCell	COVID-19-kidney-Epi_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DLGAP1 LRP2 PARD3 ALPK2	3.41e-04	178	83	4	544379f5a6145429762258d426b876bb36c112f5
ToppCell	COVID-19-Epithelial_cells-AT1\|COVID-19 / group, cell type (main and fine annotations)	COL4A4 MYO6 PARD3 GALNT13	3.48e-04	179	83	4	a0b33bd69ffdfd5d38d80207fb40058a490aa19e
ToppCell	COVID-19-kidney-Epi_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	JPH2 PTCHD4 MEIS1 ALPK2	3.48e-04	179	83	4	e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d
ToppCell	PBMC-Mild-Hematopoietic-HSPC-HSPC-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ZNRF1 MMP2 MEIS1 EHD2	3.48e-04	179	83	4	4bb2debfc9e9f258cd38e797ef160bd440aad6af
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CAPN12 LRP2 PARD3 ALPK2	3.48e-04	179	83	4	58ae5a97fe2a14e1c6fdeb886397eb06fdaf0428
ToppCell	PBMC-Mild-Hematopoietic-HSPC\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ZNRF1 MMP2 MEIS1 EHD2	3.48e-04	179	83	4	2f690f933bf6b99abeb31766e0b22bdbe36c1ba0
ToppCell	PBMC-Mild-Hematopoietic-HSPC-HSPC\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ZNRF1 MMP2 MEIS1 EHD2	3.48e-04	179	83	4	3e2c937369b8190fd5d5a31689d029e6e89fb5e2
ToppCell	COVID-19-kidney-PCT-S2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CAPN12 DLGAP1 LRP2 ALPK2	3.56e-04	180	83	4	358923e4228035a3e90e2957392089219e90dcd7
ToppCell	droplet-Limb_Muscle-nan-18m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A2 FBLN7 RPSA MMP2	3.56e-04	180	83	4	d3d0be136fff5d3e39ecf5a5dbefc1d0d0a6c814
ToppCell	droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NR5A2 JPH2 PTCHD4 TAP1	3.56e-04	180	83	4	455d1e3ccf2ab609954f3b870e8f514ddca735f4
ToppCell	droplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRMT9B CLSTN2 GRHL3 RASGRP2	3.56e-04	180	83	4	78fdcfb3fdbf36469cae78407cda5bd0996930d8
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Alv_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL4A2 MYO6 ZNRF1 EHD2	3.56e-04	180	83	4	30cf3c7ee29694eaccb89bf8053a82037d5c9f1d
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_GGT8P\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	COL4A2 COL4A4 PTCHD4 SSPOP	3.63e-04	181	83	4	9842537f9a607d8557c43790008d175edab1f32c
ToppCell	PBMC-Mild-Hematopoietic-HSPC-HSPC-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ZNRF1 MMP2 MEIS1 EHD2	3.63e-04	181	83	4	e7f7b519c2a01c15f26df11ec9b434c0d1630c7a
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CAPN12 DLGAP1 LRP2 ALPK2	3.63e-04	181	83	4	9542c19edc9bd2cba68c01c2a8407705398e3011
ToppCell	droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A2 MYO6 NR5A2 ITPR2	3.63e-04	181	83	4	92d44892bb15771f0ab5fe61879b204b0acbd9b3
ToppCell	PBMC-Mild-Hematopoietic-HSPC-HSPC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	ZNRF1 MMP2 MEIS1 EHD2	3.63e-04	181	83	4	54a19cf6a3b752e2391feb8b316bebee0e602d17
ToppCell	PBMC-Mild-Hematopoietic-HSPC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	ZNRF1 MMP2 MEIS1 EHD2	3.63e-04	181	83	4	5b84625b1d3737708001b64f6da9360330d39a27
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CAPN12 DLGAP1 LRP2 ALPK2	3.63e-04	181	83	4	8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LRP2 PARD3 PTCHD4 ALPK2	3.63e-04	181	83	4	6956ecd6264f7469a25e555673bce4eb97d28f7a
ToppCell	PBMC-Control-Hematopoietic-HSPC-HSPC\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ZNRF1 MMP2 MEIS1 EHD2	3.71e-04	182	83	4	d0ebf2f0d5370458ab81485a0017c311077133d5
ToppCell	PBMC-Control-Hematopoietic-HSPC-HSPC-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ZNRF1 MMP2 MEIS1 EHD2	3.71e-04	182	83	4	2a6d1246bfb5899a0861c7f2f8fb9b43b0df8acc
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FAT2 SLC39A6 GRHL3 ALOX5	3.71e-04	182	83	4	678eadd57e7e830fc2bf9fd35616d3badce01705
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FAT2 SLC39A6 GRHL3 ALOX5	3.71e-04	182	83	4	8d1229fa5aa6e2e38f2ac6fe4f4dc89752fe9344
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL4A2 MYO6 ZNRF1 MEIS1	3.71e-04	182	83	4	a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50
ToppCell	PBMC-Control-Hematopoietic-HSPC\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ZNRF1 MMP2 MEIS1 EHD2	3.71e-04	182	83	4	918286422b3eab32d962b49aa07b1b9512e51d9d
ToppCell	343B-Lymphocytic-CD4_T-cell-Treg_cell_1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	PCF11 FBLN7 FAM193A SLC2A14	3.79e-04	183	83	4	807d64deaf4e50dccf6f831f88578a6d903c1421
ToppCell	COPD-Epithelial-ATII\|World / Disease state, Lineage and Cell class	MYO6 LRP2 PARD3 LDLR	3.79e-04	183	83	4	8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9
ToppCell	facs-Heart-RA-18m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRMT9B TRPV2 GRHL3 RASGRP2	3.79e-04	183	83	4	0f02136359787bd78146617990968baa47a65d86
ToppCell	3'-Child09-12-SmallIntestine-Mesenchymal-myocytic-myofibroblast\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL4A2 JPH2 MMP2 EHD2	3.79e-04	183	83	4	6b5eef96b28911c752a8b6c0975918c4572cec38
ToppCell	facs-Heart-RA-18m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRMT9B TRPV2 GRHL3 RASGRP2	3.79e-04	183	83	4	2f0dcc65ad4d90ef946919b4462280fdd20c5ea0
Drug	Acemetacin [53164-05-9]; Up 200; 9.6uM; HL60; HT_HG-U133A	COL4A2 TRMT9B MORN1 COQ6 PPP6R2 ALOX5 MVK	6.71e-06	195	82	7	2411_UP
Drug	E 5110	PPIG COQ6 ALOX5	7.28e-06	11	82	3	CID006438164
Drug	benzoquinone	TPR POLG RPS6KB1 COQ6 MMP2 TAP1 ALOX5	1.05e-05	209	82	7	CID000004650
Drug	adenophostin A	ITPR2 ITPR3	1.28e-05	2	82	2	ctd:C085029
Disease	arteriosclerosis (is_implicated_in)	MMP2 LDLR ALOX5	8.47e-05	31	81	3	DOID:2349 (is_implicated_in)
Disease	autosomal dominant polycystic kidney disease (biomarker_via_orthology)	RPS6KB1 LRP2	1.55e-04	7	81	2	DOID:898 (biomarker_via_orthology)
Disease	omega-6 polyunsaturated fatty acid measurement	ABCB11 PTCHD4 PPP6R2 LDLR MVK	2.14e-04	197	81	5	EFO_0005680
Disease	Motor retardation	ERCC6 HACE1	2.65e-04	9	81	2	C0424230
Disease	autosomal dominant cerebellar ataxia (implicated_via_orthology)	ITPR2 ITPR3	4.83e-04	12	81	2	DOID:1441 (implicated_via_orthology)
Disease	Metabolic Bone Disorder	LRP2 MMP2	6.63e-04	14	81	2	C0005944
Disease	Testicular Germ Cell Tumor	MMP2 ALOX5	6.63e-04	14	81	2	C1336708
Disease	Hereditary hearing loss and deafness	COL4A4 MYO6 TRIOBP CLRN1	7.12e-04	146	81	4	cv:C0236038
Disease	Osteopenia	LRP2 MMP2	7.64e-04	15	81	2	C0029453
Disease	myelodysplastic syndrome (implicated_via_orthology)	POLG CREBBP	7.64e-04	15	81	2	DOID:0050908 (implicated_via_orthology)
Disease	Alcohol abuse	ALDH1A1 MMP2 LDLR	8.41e-04	67	81	3	C0085762
Disease	Non-alcoholic Fatty Liver Disease	NR5A2 ALDH1A1 LDLR	9.55e-04	70	81	3	C0400966
Disease	Nonalcoholic Steatohepatitis	NR5A2 ALDH1A1 LDLR	9.55e-04	70	81	3	C3241937
Disease	esophagus squamous cell carcinoma (is_marker_for)	MMP2 PBX3 TAP1	1.12e-03	74	81	3	DOID:3748 (is_marker_for)
Disease	cortisol measurement	CNTNAP5 LDLR	1.37e-03	20	81	2	EFO_0005843
Disease	Renal glomerular disease	COL4A4 CREBBP	1.81e-03	23	81	2	C0268731
Disease	Glomerulopathy Assessment	COL4A4 CREBBP	1.81e-03	23	81	2	C4521256
Disease	lipid measurement, lipoprotein measurement	PPP6R2 LDLR MVK	1.97e-03	90	81	3	EFO_0004529, EFO_0004732
Disease	nephrotic syndrome (implicated_via_orthology)	COQ6 ALOX5	1.98e-03	24	81	2	DOID:1184 (implicated_via_orthology)
Disease	Dyslipidemias	NR5A2 LDLR	1.98e-03	24	81	2	C0242339
Disease	Dyslipoproteinemias	NR5A2 LDLR	1.98e-03	24	81	2	C0598784
Disease	age-related hearing impairment	MYO6 TRIOBP CLSTN2 MMP2 PBX3	2.01e-03	324	81	5	EFO_0005782
Disease	corpus collosum mid-posterior volume measurement	CNTNAP5 KCNV2	2.14e-03	25	81	2	EFO_0010300
Disease	Squamous cell carcinoma of esophagus	FAT2 SLC39A6 CREBBP	2.30e-03	95	81	3	C0279626
Disease	retinitis pigmentosa (implicated_via_orthology)	CWC27 CLRN1	2.50e-03	27	81	2	DOID:10584 (implicated_via_orthology)
Disease	hearing impairment	ERCC6 TRIOBP CLRN1	2.51e-03	98	81	3	C1384666
Disease	Cerebral Hemorrhage	COL4A2 MMP2	2.69e-03	28	81	2	C2937358
Disease	primary biliary cholangitis (biomarker_via_orthology)	RPS6KB1 MMP2	2.69e-03	28	81	2	DOID:12236 (biomarker_via_orthology)
Disease	Autosomal Dominant Parkinsonism	POLG ALDH1A1	2.69e-03	28	81	2	C0752098
Disease	Autosomal Dominant Juvenile Parkinson Disease	POLG ALDH1A1	2.69e-03	28	81	2	C0752097
Disease	Parkinsonism, Experimental	POLG ALDH1A1	2.69e-03	28	81	2	C0752101
Disease	Autosomal Recessive Parkinsonism	POLG ALDH1A1	2.69e-03	28	81	2	C0752100
Disease	Familial Juvenile Parkinsonism	POLG ALDH1A1	2.69e-03	28	81	2	C0752104
Disease	Ramsay Hunt Paralysis Syndrome	POLG ALDH1A1	2.69e-03	28	81	2	C0242423
Disease	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	POLG ALDH1A1	2.69e-03	28	81	2	C1868675
Disease	pancreatic cancer (is_marker_for)	ALDH1A1 MMP2 ALOX5	2.74e-03	101	81	3	DOID:1793 (is_marker_for)

Protein segments in the cluster

Peptide	Gene	Start	Entry
RGLVAMANAGSHDNG	CWC27	96	Q6UX04
RGGKFHMVDGNVSGE	AHSA1	246	O95433
REGGQSNDGNMGHEA	ALPK2	1431	Q86TB3
EVGVQGGAFEGTHMG	EHD2	406	Q9NZN4
TGHAGLNTAQAGGMA	CREBBP	251	Q92793
FLMHTGAGDQGGGQA	COL4A4	1601	P53420
LMHTAAGDEGGGQSL	COL4A2	1626	P08572
VHPLAGQGVNMGFGD	COQ6	371	Q9Y2Z9
QQFDTLVGEGGGQMS	ABCB11	546	O95342
MSGNGRELGEYGFHE	ALDH1A1	471	P00352
GQMLHGGGSRLNSGN	CRAT	306	P43155
MDGQGQRGDIISQSG	DLGAP1	571	O14490
EEEEGMGRGRHGQNG	CLSTN2	926	Q9H4D0
ANMNGIHSELNGGGE	FAM193A	321	P78312
LHCQQAGGILGDEMG	ERCC6	521	Q03468
HEALFTMGGNAEGQP	MMP2	276	P08253
FARQGIHDMLEHGGN	PACRG	126	Q96M98
QDGGNNVMRTIHGVG	ITPR2	911	Q14571
MNHGLRNGGGVGDIL	ITPR3	2466	Q14573
DGQPMGGFVMDGQQH	MEIS1	351	O00470
GGFVMDGQQHMGIRA	MEIS1	356	O00470
GMREGHGFLVDRDGQ	MORN1	116	Q5T089
VGGNSRGHFVMQRSD	FBLN7	376	Q53RD9
LAGVNLAGHSVQGGM	PBX3	11	P40426
GQFTNGMRHGYGVRQ	JPH2	131	Q9BR39
FGNLDFERSQHGSGM	MCM8	756	Q9UJA3
LGGRMGFVHNFQESN	RASGRP2	491	Q7LDG7
GEDEFQGGMVGKIHA	FAT2	3541	Q9NYQ8
LHFQFEGGESRTGMN	PARG	366	Q86W56
VHTGMLNEGGGYEND	PDPR	561	Q8NCN5
GRMNGFIDQIDGIVH	COPS4	346	Q9BT78
GIAVRFHGEEGMGQG	HACE1	581	Q8IYU2
RGLHEQIFGQGGEMP	POLG	81	P54098
EGGQLNESMDHGGVG	RPS6KB1	46	P23443
GHRAYIGRVGMDGTN	LRP2	3341	P98164
GLDDVVGFMHNAQAG	GAL3ST4	321	Q96RP7
GQAHGADRSGKDGVM	SLC2A14	491	Q8TDB8
VHGGQEQALDSPRGM	NUTM1	536	Q86Y26
DFMVQGGDFSEGNGR	PPIG	71	Q13427
EKVGIFNCHGMGGNQ	GALNT13	451	Q8IUC8
GVGMRFEGPHGQSVA	PCF11	951	O94913
NEKVGIFNCHGMGGN	GALNT1	451	Q10472
RGGHMNEAFVDFTGG	CAPN12	196	Q6ZSI9
SHPVTQVRNMGFGDG	GRHL3	586	Q8TE85
GMVQAGGQGHGLARV	LINC00304	16	Q8N9R0
MEALLEGIQNRGHGG	CEP63	1	Q96MT8
NGERLGTYMGHTGAV	EIF3I	41	Q13347
GHFSQGLADMEVQPG	IGFN1	456	Q86VF2
SMQGDGVLFHGEGQR	CNTNAP5	211	Q8WYK1
EANDHTQAAGGMRRG	PPP6R2	461	O75170
GGHGFNARVMLETQE	PARD3	1271	Q8TEW0
GLARSHGEQGQMPEN	NR5A2	51	O00482
AGTHLGGTNLDFQME	RPSA	21	P08865
EGGVNHENGMNRDGG	RHOXF1	51	Q8NHV9
QTGMSDGGGVQDQAR	ERVW-1	111	Q9UQF0
GHNIGKRMTCGDFIG	PSD	666	A5PKW4
GAMAGSGQEGRQQAV	SSPOP	426	A2VEC9
NATGGGGHVQMVQRA	ALOX5	426	P09917
MGGDENRGVTGHFTF	PSG8	126	Q9UQ74
TVEEMQQHSGQGEGG	KCNV2	281	Q8TDN2
MKDGRNSFIGHQLGG	PTCHD4	141	Q6ZW05
IQMQCHRLFEDGGGG	SLITRK3	701	O94933
AVVGNGGILNNSHMG	ST6GALNAC1	366	Q9NSC7
EGGAIREGGTHQQLM	TAP1	716	Q03518
HQGGNLLMGVGAEGI	CCT8L1P	471	A6NM43
HQGGNLLMGVGTEGI	CCT8L2	471	Q96SF2
DQLRGFIASQGMGNG	TRIOBP	2256	Q9H2D6
MGDGLHNFSDGLAIG	SLC39A6	601	Q13433
MQYGLFHGEGVRQCG	CLRN1	61	P58418
GNMGVFDPTEIHNRG	CNIH4	91	Q9P003
TIMNGHGGGRSQQTL	UBAP2	641	Q5T6F2
YQLAAHLREGGGAMG	ZFHX2	786	Q9C0A1
TETEESMGGGEGNHR	TPR	2016	P12270
SMGGGEGNHRAADSQ	TPR	2021	P12270
FNRQRGVSHAMGGRG	TPR	2341	P12270
QGERMIHGNPSGVDN	MVK	191	Q03426
GMGELAFQEQLHFRG	TRPV2	606	Q9Y5S1
VFSVNGARGNHMDFG	RWDD2B	281	P57060
DHQGEMRRNGGGNFL	TRMT9B	336	Q9P272
QGIFMGEHREGFETQ	ZNF699	86	Q32M78
EGVRSGFAMAGHENL	HIVEP2	736	P31629
EMFVSRGGHGQQDLF	TBC1D10A	166	Q9BXI6
NGYQETGGGHHRDGM	ZNRF1	101	Q8ND25
LQVFHDSQGGPGDMQ	WDR64	401	B1ANS9
TMSHQALGDVAGRGN	LDLR	766	P01130
HPTDGFQMGNIVDIG	MYO6	11	Q9UM54